Aurobindo ties up with Biotechnology Industry Research Assistance Council for COVID-19 vaccine

Aurobindo Pharma said it is developing a vaccine for COVID-19 through its wholly-owned US subsidiary, Auro Vaccines. The vaccine candidate is based on a proprietary vaccine delivery platform of the company.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/33sjrsc
via IFTTT